Animalcare Group PLC
LSE:ANCR

Watchlist Manager
Animalcare Group PLC Logo
Animalcare Group PLC
LSE:ANCR
Watchlist
Price: 238 GBX -0.83% Market Closed
Market Cap: 164.2m GBX
Have any thoughts about
Animalcare Group PLC?
Write Note

Animalcare Group PLC
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Animalcare Group PLC
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Animalcare Group PLC
LSE:ANCR
Common Shares Outstanding
ÂŁ60.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
11%
GlaxoSmithKline PLC
LSE:GSK
Common Shares Outstanding
ÂŁ4.1B
CAGR 3-Years
0%
CAGR 5-Years
-4%
CAGR 10-Years
-2%
AstraZeneca PLC
LSE:AZN
Common Shares Outstanding
$1.6B
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
2%
Verona Pharma PLC
NASDAQ:VRNA
Common Shares Outstanding
$654.6m
CAGR 3-Years
11%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Common Shares Outstanding
$221.1m
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
1%
Dechra Pharmaceuticals PLC
LSE:DPH
Common Shares Outstanding
ÂŁ113.9m
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
3%
No Stocks Found

Animalcare Group PLC
Glance View

Market Cap
164.2m GBX
Industry
Pharmaceuticals

Animalcare Group Plc engages in the development, sale, and supply of generic veterinary medicines and animal identification products. The company is headquartered in Ripon, North Yorkshire. The company went IPO on 2008-01-15. The firm is focused on developing and commercializing prescription and over-the-counter pharmaceutical products. The firm operates in three categories within the veterinary market, which includes Companion Animals, Equine and Production Animals. The company manages international supply chain, including specialist veterinary wholesalers and distributors. The firm develops, supplies and markets products and services to the veterinary profession. The company focuses on therapeutic areas, which includes pain management, dermatology and anti-infectives. The Company’s product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs.

ANCR Intrinsic Value
336.99 GBX
Undervaluation 29%
Intrinsic Value
Price

See Also

What is Animalcare Group PLC's Common Shares Outstanding?
Common Shares Outstanding
60.4m GBP

Based on the financial report for Jun 30, 2024, Animalcare Group PLC's Common Shares Outstanding amounts to 60.4m GBP.

What is Animalcare Group PLC's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
11%

Over the last year, the Common Shares Outstanding growth was 0%.

Back to Top